Ascentage Pharma Group International (AAPG) Work In Process (2023 - 2025)

Ascentage Pharma Group International (AAPG) has 3 years of Work In Process data on file, last reported at $3.6 million in Q4 2025.

• For the quarter ending Q4 2025, Work In Process rose 839.14% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 839.14% YoY), and the FY2025 full-year result was $3.6 million, up 870.05% from the prior year.
• Work In Process for Q4 2025 stood at $3.6 million, up from $380894.2 in the prior quarter.
• Across five years, Work In Process topped out at $3.6 million in Q4 2025 and bottomed at $380894.2 in Q4 2024.
• The 3-year median for Work In Process is $706797.9 (2023), against an average of $1.6 million.
• The widest annual swing landed in 2024, when Work In Process tumbled 46.11%; it then surged 839.14% in 2025.
• A 3-year view of Work In Process shows it stood at $706797.9 in 2023, then tumbled by 46.11% to $380894.2 in 2024, then soared by 839.14% to $3.6 million in 2025.
• The last three Work In Process figures came in at $3.6 million (Q4 2025), $380894.2 (Q4 2024), and $706797.9 (Q4 2023), per Business Quant data.

Peer Comparison